Clinical trials
Completed Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
5,501 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 48 |
| 2001 | 56 |
| 2002 | 78 |
| 2003 | 103 |
| 2004 | 146 |
| 2005 | 182 |
| 2006 | 235 |
| 2007 | 248 |
| 2008 | 221 |
| 2009 | 237 |
| 2010 | 258 |
| 2011 | 253 |
| 2012 | 266 |
| 2013 | 258 |
| 2014 | 234 |
| 2015 | 282 |
| 2016 | 278 |
| 2017 | 260 |
| 2018 | 274 |
| 2019 | 271 |
| 2020 | 262 |
| 2021 | 269 |
| 2022 | 214 |
| 2023 | 187 |
| 2024 | 123 |
| 2025 | 60 |
| 2026 | 12 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5,501 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 187 |
| GlaxoSmithKline | 94 |
| Novartis Pharmaceuticals | 81 |
| AstraZeneca | 71 |
| M.D. Anderson Cancer Center | 70 |
| Bayer | 67 |
| Amgen | 60 |
| Eli Lilly and Company | 58 |
| Boehringer Ingelheim | 57 |
| Memorial Sloan Kettering Cancer Center | 55 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms | 5,501 |
| Breast Neoplasms | 393 |
| Neoplasm Metastasis | 315 |
| Prostatic Neoplasms | 218 |
| Carcinoma, Non-Small-Cell Lung | 211 |
| Colorectal Neoplasms | 199 |
| Lung Neoplasms | 178 |
| Pain | 172 |
| Melanoma | 151 |
| Ovarian Neoplasms | 147 |
Trials
Showing 1 to 25 of 5,501. Each trial links to its page on Pharma Observatory.
5,401 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.